Antrodia cinnamomea supplement to improve quality of life during chemotherapy for lung cancer
Official title: The Effects of Antrodia Cinnamomea Fruiting Body Extract on Quality of Life and Chemotherapy Side Effects in Patients With Lung Cancer Undergoing Platinum-Based Chemotherapy
Run by Tri-Service General Hospital (TSGH) · NCT07241182 · Data updated 2026-11-12
This trial will test whether taking a daily Antrodia cinnamomea-containing capsule helps people with lung cancer on platinum chemotherapy feel better by reducing nausea, improving sleep, and easing cancer-related symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Tri-Service General Hospital (TSGH) Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | November 24, 2025 |
| Main results expected | March 31, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | January 8, 2026 |
| Trial ID | NCT07241182 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age >18) with pathologically or radiographically confirmed lung cancer who are receiving platinum-based chemotherapy, have a life expectancy of at least six months, can take daily oral supplements, and meet laboratory and clinical safety requirements are ideal candidates.
✕Probably not a fit
Patients already taking Antrodia camphorata supplements, those with abnormal recent liver or kidney tests, active acute infections, major cardiac disease, severe neuropathy, known allergies to study ingredients, or those unable to comply with daily supplementation may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with pathologically or radiographically confirmed lung cancer who are receiving platinum-based chemotherapy at Tri-Service General Hospital will be randomly assigned in a double-blind manner to receive either a capsule containing Antrodia cinnamomea plus turmeric and probiotics or a capsule with turmeric and probiotics only. Participants will take the assigned capsules daily for three months with continued follow-up for a total of six months (24 weeks). Researchers will use validated questionnaires to measure nausea and vomiting, sleep quality, overall quality of life, and other cancer-related symptoms and will compare outcomes between the two groups. The trial is conducted at Tri-Service General Hospital in Taipei and is sponsored by that hospital with collaboration from Balay Biotechnology Corporation.
Why it matters
Potential benefit: If successful, the supplement could reduce chemotherapy-related nausea, improve sleep, and meaningfully improve overall quality of life for patients receiving platinum-based chemotherapy for lung cancer.
How similar studies have gone: There are limited clinical data specifically on Antrodia cinnamomea for chemotherapy side effects; some preclinical and small human studies suggest potential benefits but robust randomized evidence is lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pathologically and radio-graphically diagnosed lung cancer * Age greater than 18 years * Received platinum-based chemotherapy * Life expectancy of six months or longer Exclusion Criteria: * Inability to comply with timely supplementation administration. * Within 14 days prior to trial entry, laboratory data showing abnormal liver function, abnormal kidney function * Within 30 days prior to trial entry, unexplained fever ≥38.5°C for 7 consecutive days or chronic diarrhea for 15 consecutive days. * Currently receiving hormone therapy. * Major cardiac disease or arrhythmia severe enough that the attending physician considers the patient unsuitable for trial participation. * Major neuropathy. * Patients with currently active acute infections. * Patients with known allergies/allergic reactions to the investigational product or any components in their formulations. * Patients currently taking supplements containing Antrodia camphorata extract.
Where it's running
-
Tri-Service General Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Chen-Liang Tsai
- Email: doc10376@gmail.com
- Phone: 886-2-8792-3311
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
AI-Personalized Discharge Education After Lung Cancer Surgery
This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
-
Low-Intensity Endurance Exercise to Help Lung Cancer-Related Fatigue
This trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer in addition to their usual care.
-
Low-Intensity Endurance Exercise for Lung Cancer-Related Fatigue
A randomized trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.